Healthcare Services

Global Vagus Nerve Stimulation Market Set for Strong Expansion Reaching $2.01 Billion by 2030 at 14.5% CAGR

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Vagus Nerve Stimulation Market Over The 2026–2030 Period?

The vagus nerve stimulation market size has experienced rapid expansion in recent years. It is anticipated to increase from $1.02 billion in 2025 to $1.17 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.9%. The market’s historic growth can be attributed to several factors including the rising prevalence of epilepsy and depression, the broadening scope of neuromodulation research, the widespread availability of implantable stimulation technologies, a growing awareness of alternative neurological therapies, and the proliferation of specialty neurology clinics.

The vagus nerve stimulation market is projected to experience swift expansion in the coming years. Its valuation is set to reach $2.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.5%. This anticipated growth during the projection period stems from factors such as a heightened demand for tailored neuromodulation treatments, the escalating uptake of wearable medical devices, an broadening array of neurological disorder management solutions, an increased emphasis on non-pharmacological methods, and continuous advancements in stimulation technologies. Key trends anticipated during the forecast period encompass the surging acceptance of non-invasive vns devices, the escalating application of vns in the treatment of depression, the deepening integration of wearable neuromodulation technologies, the proliferation of home-based neuromodulation treatments, and a sharpened concentration on patient-centric stimulation protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20677&type=smp

What Drivers Are Expected To Influence The Vagus Nerve Stimulation Market During The Forecast Period?

The growing incidence of neurological conditions is anticipated to drive the expansion of the vagus nerve stimulation market in the future. A neurological disorder refers to an ailment impacting the brain, spinal cord, or nerves, resulting in difficulties with movement, sensation, cognitive abilities, or general bodily function. These disorders stem from varied causes, often encompassing a mix of genetic predispositions, environmental influences, and lifestyle choices. Furthermore, physical traumas like head injuries and spinal cord injuries can also contribute to neurological issues. Vagus nerve stimulation finds application in managing neurological disorders due to its ability to regulate brain activity and neurotransmitter levels, thereby aiding in symptom reduction for conditions including epilepsy, depression, and specific forms of migraines. For example, data from September 2024 by the Australian Institute of Health and Welfare, an Australian government body, indicates that approximately 411,100 Australians were living with dementia in 2023, a number forecast to exceed double by 2058. Consequently, the rising occurrence of neurological conditions is a significant driver for the vagus nerve stimulation market.

How Is The Vagus Nerve Stimulation Market Segmented Across Key Categories?

The vagus nerve stimulation market covered in this report is segmented –

1) By Product: Implantable Vagus Nerve Stimulation Device, External Vagus Nerve Stimulation Device

2) By Biomaterial: Metallic, Ceramics, Polymeric

3) By Application: Epilepsy, Depression, Migraine

4) By End-Use: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers

Subsegments:

1) By Implantable Vagus Nerve Stimulation Device: Pulse Generators, Leads and Electrodes, Rechargeable Implantable Devices, Non-Rechargeable Implantable Devices

2) By External Vagus Nerve Stimulation Device: Transcutaneous Vagus Nerve Stimulation Devices, Wearable VNS Devices, Portable External Stimulators, Home-use VNS Devices

What Key Developments And Trends Are Impacting The Vagus Nerve Stimulation Market?

Leading companies in the vagus nerve stimulation market are concentrating on developing technologically advanced products, such as implantable pulse generators (IPG), to deliver long-term, adaptable, and targeted treatment for chronic health issues. An implantable pulse generator (IPG) is a medical apparatus surgically inserted beneath the skin that emits electrical pulses to specific body regions to address conditions like chronic pain or neurological disorders. For instance, in February 2023, LivaNova Plc, a UK-based medical device company, launched the SenTiva DUO. The SenTiva DUO is a distinct implantable pulse generator (IPG) designed for vagus nerve stimulation (VNS) therapy, specifically tailored for treating drug-resistant epilepsy. This innovative device permits patients with existing dual-pin systems to upgrade without requiring lead revisions, providing advanced VNS therapy with customizable, automatic delivery. SenTiva DUO improves seizure control and fosters optimal treatment adherence, making it a notable progression for those seeking effective management of their condition.

Who Are The Dominant Players Shaping The Vagus Nerve Stimulation Market Landscape?

Major companies operating in the vagus nerve stimulation market are Medtronic PLC, Boston Scientific Corporation, LivaNova LLC, electroCore Inc., Soterix Medical Inc., Cleveland Medical Devices Inc., MicroTransponder Inc., Parasym Ltd., Neuvana LLC, NeuroSigma Inc., Evren Technologies Inc., Aucta Technologies Inc., SetPoint Medical Corporation, NEMOS GmbH, tVNS Technologies GmbH, Innervate Inc., Neuroelectrics Barcelona S.L., Brainstem Biometrics Inc., BioControl Medical Ltd., Cala Health Inc.

Read the full vagus nerve stimulation market report here:

https://www.thebusinessresearchcompany.com/report/vagus-nerve-stimulation-global-market-report

Which Region Is Forecast To Lead The Vagus Nerve Stimulation Market In Terms Of Market Size?

North America was the largest region in the vagus nerve stimulation market in 2025. The regions covered in the vagus nerve stimulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Vagus Nerve Stimulation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20677&type=smp

Browse Through More Reports Similar to the Global Vagus Nerve Stimulation Market 2026, By The Business Research Company

Optic Nerve Disorders Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Neurostimulation Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Electrical Stimulation Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795